{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:17:26Z","timestamp":1742800646646},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1212\/wnl.50.1.6","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:31:39Z","timestamp":1336915899000},"page":"6-7","source":"Crossref","is-referenced-by-count":17,"title":["Why do patients with McArdle's disease have decreased exercise capacity?"],"prefix":"10.1212","volume":"50","author":[{"given":"Robert L.","family":"Ruff","sequence":"first","affiliation":[{"name":"From the Departments of Neurology and Neuroscience, Case Western Reserve University School of Medicine, and Cleveland Veterans Affairs Medical Center, University Hospitals of Cleveland, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"DiMauro S Tsujino S. Nonlysosomal glycogenoses. In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed. New York: McGraw-Hill 1994:1554-1576."},{"key":"e_1_3_1_3_2","first-page":"2","volume":"141","year":"1985","unstructured":"Rowland LP. Cramps, spasms and muscle stiffness. Rev Neurol (Paris) 1985;141:261-273.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_1_4_2","unstructured":"Lewis SF Haller RG. Fatigue in skeletal muscle disorders. In: Atlan G Belivau L Bouissou P eds. Muscle fatigue: biochemical chemical and physiological aspects. Paris: Masson 1991:119-134."},{"key":"e_1_3_1_5_2","unstructured":"Kaminski HJ Ruff RL. Endocrine myopathies (hyper- and hypofunction of adrenal thyroid pituitary glands and iatrogenic glucocorticoid myopathy). In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed. New York: McGraw-Hill 1994:1726-1753."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.3"},{"key":"e_1_3_1_7_2","first-page":"5","volume":"13","year":"1965","unstructured":"Rowland LP, Araki S, Carmel P. Contracture in McArdle's disease: stability of adenosine triphosphate during contracture in phosphorylase-deficient muscle. Arch Neurol 1965;13:541-544.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.1"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198101013040101"},{"key":"e_1_3_1_10_2","first-page":"7","volume":"79","year":"1982","unstructured":"Chance B, Eleff S, Bank W, Leigh JS, Warnell R.31 P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 1982;79:7714-7718.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_11_2","first-page":"1","volume":"70","year":"1991","unstructured":"Bertocci LA, Haller RG, Lewis SF, Fleckenstein JL, Nunnally RL. Abnormal high-energy phosphate metabolism in human muscle phosphofructokinase deficiency. J Appl Physiol 1991;70:1201-1207.","journal-title":"J Appl Physiol"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220104"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1987.00520130006001"},{"key":"e_1_3_1_14_2","first-page":"6","volume":"37","year":"1987","unstructured":"Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology 1987;37:663-671.","journal-title":"Neurology"},{"key":"e_1_3_1_15_2","first-page":"3","volume":"8","year":"1980","unstructured":"Brumback RA. Iodoacetate inhibition of glyceraldehyde 3-phosphate dehydrogenase as a model of human myophosphorylase deficiency(McArdle's disease) and phosphofructokinase deficiency (Tarui's disease). J Neurol Sci 1980;8:383-398.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Ruff RL Weissman J. Iodoacetate-induced contracture in rat skeletal muscle: possible role of ADP. Am J Physiol 1991;261(Cell Physiol 30):C828-C836.","DOI":"10.1152\/ajpcell.1991.261.5.C828"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Ruff RL Weissman J. Iodoacetate-induced skeletal muscle contracture: changes in ADP calcium phosphate and pH. Am J Physiol 1995;268(Cell Physiol 37):C317-C322.","DOI":"10.1152\/ajpcell.1995.268.2.C317"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1996.81.1.1"},{"key":"e_1_3_1_19_2","first-page":"5","volume":"66","year":"1986","unstructured":"Clausen T. Regulation of active Na+-K+ transport in skeletal muscle. Physiol Rev 1986;66:542-580.","journal-title":"Physiol Rev"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201X.1996.433146000.x"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.50.1.6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:28:04Z","timestamp":1711639684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.50.1.6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1212\/WNL.50.1.6"],"URL":"https:\/\/doi.org\/10.1212\/wnl.50.1.6","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}